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ABSTRACT Neuronal plasma membranes are thought to be the primary target of the neurotoxic -amyloid peptides (A) in the
pathogenesis of the Alzheimer’s disease. Histologically, A peptides are observed as extracellular macroscopic senile plaques, and
most biophysical techniques have indicated the presence of A close to the lipid headgroup region but not in the core of the
membrane bilayers. The focus of this study is an investigation of the interaction between A and lipid bilayers from a structural point
of view. Neutron diffraction with the use of selectively deuterated amino acids has allowed us to determine unambiguously the
position of the neurotoxic fragment A (25–35) in the membrane. Two populations of the peptide are detected, one in the aqueous
vicinity of the membrane surface and the second inside the hydrophobic core of the lipid membrane. The location of the C terminus
was studied in two different lipid compositions and was found to be dependent on the surface charge of the membrane. The
localization of -amyloid peptides in cell membranes will offer new insights on their mechanism in the neurodegenerative process
associated with Alzheimer’s disease and might provide clues for therapeutic developments.
INTRODUCTION
Although their mechanism of action in the neurodegenera-
tive process has not been yet established, the -amyloid
peptides play an important role in the pathogenesis of Alz-
heimer’s disease (Beyreuther and Masters, 1997). The se-
nile plaques, typical histological lesions in the brain tissues
of Alzheimer’s disease patients, are extracellular deposits of
A peptides; they contain mainly fibrils of A with 39 to 43
amino acid residues, intermixed with shorter fragments of
the peptide in amorphous form (Selkoe, 1999). Besides
neuritic plaques, Alzheimer’s disease is also characterized
by intraneuronal tangles of polymerized  protein (Man-
delkow and Mandelkow, 1998). These two lesions can
develop independently of each other and can appear in
different regions of the brain of Alzheimer patients, but
there is evidence that A may trigger the cytological re-
sponse that leads to the formation of neurofibrillary tangles
(Selkoe, 1999). Nevertheless, it is not clear whether it is the
extracellular A accumulation that initiates the neurotoxic
response or if it is the monomeric (or oligomeric) form of
A that is capable of diffusing and accumulating at specific
target sites, thereby activating the cascade of pathogenic
changes in brain tissues.
A is a 39 to 43 amino acid residue peptide produced by
proteolytic cleavage of the amyloid precursor protein by
-secretase (Haass and De Strooper, 1999). A spontane-
ously aggregates in amyloid fibrils, whose toxicity to cul-
tured cortical cells is well known (Busciglio et al., 1995;
Mattson et al., 1992; Pike et al., 1993). Much of the bio-
logical activity of the full-length peptide is possessed by the
11 residues fragment A (25–35). In fact, this fragment has
been proved to have a cytotoxic effect on human cerebral
cortical cell cultures (Mattson et al., 1992) and to modulate
membrane lipid peroxidation (Walter et al., 1997). Its three-
dimensional structure in a membrane-mimicking environ-
ment has been solved by NMR study (Kohno et al., 1996),
revealing an -helix structure in the C-terminal region,
embedded in detergent micelles. This model would fit with
the hydrophobicity of the seven amino acid residues in the
C terminus, most likely to be embedded in the membrane,
whereas the four residues of the N terminus, including a
positively charged lysine, would be in the vicinity of the
hydrophilic environment.
Several studies indicate that A neurotoxicity may be
mediated, at least in part, by direct interactions between the
peptide and the membrane lipids. In particular A (1–40)
forms cation-selective channels across acidic phospholipid
bilayer membranes, and it was suggested that these channels
disrupt ion homeostasis and hence cause toxicity (Arispe et
al., 1993; Mirzabekov et al., 1994). Membrane disruption
by A peptides mediated through binding to phospholipids
or protein membranes has also been reported (McLaurin and
Chakrabartty, 1996).
A prerequisite for any understanding of the interaction of
the peptide with the membrane is knowledge of its exact
location at the membrane. At present, the published data are
highly controversial (Mason et al., 1999; Shao et al., 1999;
Terzi et al., 1994, 1997), and most results have been ob-
tained by the application of indirect methods and/or inap-
propriate target systems such as lipid monolayers or deter-
gent micelles. Besides the overwhelming quantity of papers
considering the extracellular location of A in the senile
plaques, some studies suggest that the A peptides bind
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electrostatically only to the polar headgroups, i.e., do not
become embedded within the hydrophobic interior. On the
other hand, the only structural localization by x-ray diffrac-
tion indicates that the fragment A (25–35) inserts, at
physiological pH, into the hydrophobic core of net-un-
charged lipid membranes (Mason et al., 1996).
We investigated the interaction of A (25–35) with ori-
ented lipid bilayer samples by neutron diffraction, and the
interaction and depth of penetration of the C terminus in the
bilayer core were determined. Neutron diffraction experi-
ments are indeed a sensitive and direct method for delin-
eating the structure of the bilayer profile. In the study of
biological samples, the advantage of neutron diffraction is
based on the large difference in the scattering length of
hydrogen (bH  0.37  1014 m) and deuterium (bD 
0.67  1014 m). Using the isomorphous replacement tech-
nique it is therefore possible to locate, with high sensitivity
and without perturbing the system, a selectively deuterated
part of a molecule in a structure even at lower spatial
resolution. This approach is often applied; it was used for
instance to analyze the location of retinal in bacteriorho-
dopsin (Hauss et al., 1990) and, more recently, to study the
interaction of short peptides, like substance P, with phos-
pholipid membranes (Bradshaw et al., 1998). In the present
study the penultimate amino acid in the C-terminal region of
A (25–35), a leucine containing 10 hydrogens, was selec-
tively deuterated. Diffraction patterns obtained from lipid
samples containing the deuterated and the protonated spe-
cies of A (25–35), respectively, were compared. A mixture
of 92:8 mol/mol of 1-palmitoyl-2-oleoyl-phosphatidylcho-
line (POPC) and 1-palmitoyl-2-oleoyl-phosphatidylserine
(POPS) was used to mimic, as closely as possible, the
composition and the negative charge state of neuritic cell
membranes without increasing the complexity of the system
too much. To gain information about the effect of anionic
lipids on the peptide/membrane interaction, a system in
which the lipid matrix consisted of neutral lipids only (i.e.,
POPC) was also investigated.
MATERIALS AND METHODS
Sample preparation
A (25–35) peptide (GSNKGAIIGLM) was synthesized and purified to
95% by WITA GmbH (Teltow, Germany). Two batches of the peptide
were prepared, one protonated and one containing a deuterated leucine (10
deuterons) at position 34. To avoid preaggregation and to maintain the
peptide in its monomeric form, a pretreatment with trifluoroacetic acid
(TFA) (Jao et al., 1997) was applied. The peptide-TFA solution was dried
in a quartz tube under a stream of nitrogen and put under vacuum (p  1
mbar) for 12 h to remove all traces of TFA.
POPC and the net negatively charged lipid POPS were purchased from
Avanti Polar Lipid (Alabaster, AL). Chloroform solutions both of POPC or
of a mixture of POPC/POPS (92:8 m/m) were prepared and added to the
dried pretreated peptide. The samples contained 20 mg of lipids and 3
mol% peptide to have a sample with A concentration as low as possible.
This condition was chosen on the basis of our previous successful work on
the localization of deuterated retinals in bacteriorhodopsin (Hauss et al.,
1990). In that case the difference in scattering length between the mem-
branes with deuterated and protonated retinals, respectively, was in the
range of 6% to 13%. We chose, therefore, a peptide to lipid ratio resulting
in a difference of scattering length in the same range (i.e., 13.8% in 100%
H2O). Control samples, containing only the lipid mixtures, were also
prepared. To check the reproducibility of the sample preparation, we
produced a second independent sample with a POPC/POPS mixture and
protonated peptide; this sample was scanned in a second measuring time at
the membrane diffractometer.
Oriented samples were obtained by spraying the solutions, using an
artist’s airbrush, onto quartz slides (65 mm  15 mm  0.3 mm), covering
only the central area of one side. Traces of the solvent were removed by
placing the slides in a vacuum dessicator for 12 h (p  1 mbar). Samples
were then rehydrated for 24 h at room temperature in an atmosphere of
98% relative humidity, maintained with a saturated K2SO4 solution. Since
the samples were rehydrated in this way, they contained pure water, with
no salts, and it was not possible to measure the pH of the samples.
Neutron diffraction and data analysis
Neutron diffraction measurements were carried out on the membrane
diffractometer V1 at the Berlin Neutron Scattering Center of the Hahn-
Meitner-Institute (Berlin, Germany). The samples were placed vertically in
a standard aluminum container in which the temperature was controlled
(T  27.0  0.1°C for all samples) and humidity adjusted by aqueous
saturated solutions of K2SO4 in Teflon water baths at the base of the
chamber. A temperature gradient between sample and container can be
excluded because no condensation was observed on the samples or inside
the can after each experiment. Contrast variation was achieved by adjusting
the atmosphere in the sample container to three different compositions of
D2O:H2O (i.e., 100:0, 50:50, and 0:100). After each change of the aqueous
solution, the samples were let to equilibrate for 24 h.
Preliminary -2 scans were performed to check the absence of nonla-
mellar reflections. Diffraction intensities were measured with rocking
scans, rocking the sample around the expected Bragg position  by   2o.
The duration of each rocking scan varied from 20 min to 4 h depending on
the intensity of the reflection. To control the equilibrium state of the
samples, we performed the scans of the complete series of the Bragg peaks
twice, checking the reproducibility in intensity and position of each reflex,
which were found to be identical, within experimental error limits, for all
measurements. Diffraction patterns of POPC and POPC/POPS bilayers of
POPC and POPC/POPS bilayers containing 3% (mol) (D-Leu-34)-A
(25–35) and of POPC and POPC/POPS containing 3% (mol) (H-Leu-
34)-A (25–35) were measured (data not shown). The lamellar spacing d
of each sample was calculated by least-square fitting of the observed 2
values to the Bragg equation n  2d  sin, in which n is the diffraction
order and  is the selected neutron wavelength (4.53 Å). Integrated inten-
sities were calculated with Gaussian fits to the experimental Bragg reflec-
tions; due to the intensity distribution of the primary neutron beam, a
Gaussian is a very good approximation of the shape of a reflection. Intensities,
corrected with absorption and Lorentz factors, were square-rooted to produce
the structure factor amplitudes. We calculated the linear absorption coefficient
 for   4.53 Å to   (5.55  x  1.05) cm1 (x is the mole ratio
H2O:D2O) with the scattering cross-sections found in Sears (1992) according
to the formula given in Franks and Lieb (1979). The largest absorption
correction occurred in 100% H2O for the first Bragg reflex and was 1.7%.
The data were placed on a “relative absolute” scale following a procedure
described by Wiener and White (1991) using the known neutron scattering
length of D and H to scale the differences between homologous samples in
D2O and H2O atmosphere and between homologous deuterated and protonated
samples. The number of water molecules, necessary to perform the scaling,
was measured gravimetrically. The samples were repeatedly weighted in the
wet and in the dry state, and from the weight difference the amount of water
was determined with precision better than 5%. This procedure gave 16.2 1.8
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and 10.0  1.5 water molecules per lipid for the POPC/POPS and POPC
mixtures, respectively. The error in the determination of the number of water
molecules results in an error in the average scattering length density per unit
length (Wiener and White, 1991).
The relative absolute density profile 	(z) is given by
	z

2
d h0
n
Fh cos2hzd  (1)
in which F is in units of scattering length and 	0(z)  2⁄d F0 is the average
scattering length per unity length of the bilayer, F(h) are the scaled
structure factors, and the sum describes the distribution in scattering
lengths across the bilayer.
To estimate the significance of any feature in the scattering length
density profiles, knowledge of the error limits in the profiles is necessary.
The error in the scattering length density profiles corresponding to the
desired confidence limit is given by:
		z
 t
var	z1/2 (2)
in which t is the Student’s t factor and var(	(z)) the variance of 	(z).
Because the structure factors are independent of each other, Eq. 2 reads:
		z

2t
d  h0
n
	Fh2 cos22hzd 
1/2
(3)
The error 	F was first determined with the counting statistics and the
variation of the baseline for each reflection and is given in Table 1. In an
ideal experiment the differences of corresponding structure factors between
samples with protonated and deuterated peptide in various D2O:H2O ratios
are identical within the statistical error limit. In a real experiment system-
atical errors may contribute to the measured data points. In our experiment
a slight difference in humidity introduce such an error. An estimate of the
error comes from the comparison of any difference between corresponding
data points and is used in the further analysis. The confidence limit used in
this paper was 95% (t  1.96).
The phase assignment was obtained with the isomorphous replacement
method, using the D2O:H2O exchange, where the structure factors are
linear function of the mole fraction D2O:H2O (Franks and Lieb, 1979).
Structure factors at three different isotopic water vapor compositions were
measured for each sample. For any further data evaluation, i.e., for the
localization of the label, only the structure factors obtained at 0% D2O
were used. It is not appropriate to use the structure factors at 100% or 50%
D2O to determine the label position via the Fourier difference method. At
these contrasts the large coherent scattering of the water layer covers that
of the membrane. The difference in coherent scattering length due to the
labeled A is reduced to 1.3% only compared with 13.8% in 100% H2O
and becomes barely detectable. The position of the deuterated amino acid
was determined by the differences of the densities between samples with
A containing deuterated and protonated leucine on a relative absolute
scale. The distribution of the label was fitted in reciprocal space to the
position and amplitude of a Gaussian function using the measured structure
factors up to the fifth order.
RESULTS AND DISCUSSION
Diffractograms showed up to five orders for each measured
sample (data not shown). A mosaicity inferior to 0.5° was a
TABLE 1 Experimental structure factors of all the samples investigated, corrected, and scaled as described in the text
F (0) F (1) F (2) F (3) F (4) F (5)
POPC/POPS
100% D2O 31.2  0.1 10.9  0.5 2.17  0.07 0 6.15  0.06
50% D2O 16.4  0.2 1.64  0.01 4.37  0.08 0 5.74  0.05
0% D2O 0.31  0.02 1.57  0.01 7.63  0.05 4.37  0.03 0 4.37  0.05
POPC/POPS  A(25–35) protonated sample 1
100% D2O 26.80  0.3 10.2  0.1 2.04  0.02 0 2.95  0.04
50% D2O 14.72  0.1 1.00  0.03 3.36  0.03 0 2.54  0.05
0% D2O 0.36  0.02 2.65  0.02 8.78  0.05 4.50  0.03 0 2.08  0.04
POPC/POPS  A(25–35) protonated sample 2
100% D2O 25.56  0.3 12.7  0.1 2.01  0.02 1.05  0.05 3.90  0.04
50% D2O 14.46  0.1 1.64  0.04 3.60  0.03 0.46  0.05 3.15  0.04
0% D2O 0.45  0.03 2.30  0.02 8.45  0.04 5.05  0.04 0 2.50  0.04
POPC/POPS  A(25–35) deuterated
100% D2O 29.96  0.3 10.69  0.01 2.12  0.02 0 3.25  0.03
50% D2O 16.30  0.2 1.34  0.02 3.05  0.02 0 2.81  0.03
0% D2O 1.32  0.06 2.66  0.06 7.72  0.01 3.78  0.03 1.20  0.05 2.37  0.02
POPC
100% D2O 37.9  0.4 18.8  0.1 2.43  0.08 3.12  0.18 7.03  0.5
50% D2O 24.46  0.2 2.84  0.01 6.44  0.10 2.68  0.16 5.91  0.6
0% D2O 1.37  0.06 4.34  0.06 12.83  0.05 10.36  0.07 0.81  0.05 4.51  0.5
POPC  A(25–35) protonated
100% D2O 42.31  0.3 17.9  0.1 2.84  0.10 4.13  0.3 7.2  0.5
50% D2O 25.09  0.2 2.71  0.08 6.46  0.17 3.94  0.4 5.4  0.6
0% D2O 1.60  0.06 4.34  0.04 13.4  0.1 9.97  0.10 2.68  0.3 4.30  0.35
POPC  A(25–35) deuterated
100% D2O 50.05  0.5 22.0  0.2 4.36  0.4 0 7.03  0.4
50% D2O 27.74  0.3 3.26  0.03 7.26  0.19 0 6.88  0.4
0% D2O 1.68  0.08 3.89  0.04 15.6  0.1 9.97  0.20 0 6.20  0.7
The reported errors are derived from the counting statistics and baseline variation. F (0) values are derived from the lipid membrane composition and the
water content of each sample (see text) and are in units of 1014 m.
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proof of the excellent quality of the samples. Significant
relative intensity changes could be observed either between
the pure lipid and the peptide containing samples and be-
tween the lipid samples containing the protonated and deu-
terated A (25–35) peptide. Table 1 summarizes the struc-
ture factors experimentally determined, corrected, and
scaled as described in Materials and Methods. F (0) values,
calculated at 0% D2O, are listed as well. Fig. 1 shows an
example of the phase assignment of the structure factors
using the D2O/H2O exchange. Here the assumption is made
that the water layer can be modeled as a Gaussian centered
at the unit cell boundaries; this defines the phases of the
associated structure factors Fw as      for the first
five orders. In Fig. 1 the functions F  xFw  FM, with FM
as structure factors of the membrane, are plotted as a func-
tion of the molar D2O:H2O ratio x. The structure factors in
Table 1 are phased accordingly. The largest values of the
difference structure factors for homologous samples are
obtained for F1 and F2 in 100% D2O. These structure
factors are indeed the most sensitive to the difference in
water content of the various samples, which is quite difficult
to control at the high humidity levels. On the other hand,
high humidity is desirable to stay as close as possible to
physiological conditions.
POPC/POPS multilayers
The calculated d spacings at 98% relative humidity were
56.7  0.4 Å, 56.9  0.4 Å, and 57.0  0.4 Å for the
POPC/POPS, the POPC/POPS with protonated, and the
POPC/POPS with deuterated A (25–35), respectively. Fig.
2 A exhibits the scattering length density profiles along the
normal to the membrane plane obtained via Fourier synthe-
sis from the structure factors at 0% D2O as described in
Materials and Methods. The reported patterns represent the
elementary cell of the oriented samples, i.e., one lipid bi-
layer with its hydration shell; the center of the elementary
cell is the middle of the bilayer profiles, occupied by the
terminal methylene groups of the phospholipids. The water
layers are centered at the two edges of the diagram at z 
28.5 Å and z  28.5 Å. All the profiles were calculated
using structure factors representing 0% D2O as discussed in
Materials and Methods. The two main peaks in the profiles
(at 16.5 Å and 16.5 Å) represent the polar lipid head-
groups, near the glycerol backbone, which contain fewer
FIGURE 1 Example of the structure factors and their phase assignment
using H2O/D2O exchange, in this instance POPC/POPS multilayers con-
taining deuterated A (25–35). The errors are estimated as described in the
text and where not shown are smaller than the symbols.
FIGURE 2 (A) Scattering length density profiles times lipid area (	*z)
S 	(z)) in the direction normal to the membrane plane of the two samples
containing deuterated (solid) and protonated (dashed) A (25–35) in the
case of an anionic POPC/POPS membrane. The profile of a pure lipid
sample (dotted) is shown as a reference. (B) Difference scattering length
density profile of the sample with protonated and deuterated A (25–35)
(solid line) and its fit to two Gaussian distributions (dotted line) truncated
to the fifth Fourier term. Two distinct locations of the deuterated label
occur, one of them is situated in the interior of the lipid bilayer, the second
in the lipid/water interface. A model of the peptide is sketched to scale
(top) with the leucine residue in two possible locations, according to our
findings. The deuterons of the labeled leucine are colored gray. The peptide
conformation is taken from Kohno et al., 1999. The sketch is only to guide
the eye, because we have no information about the orientation of the
peptide at present. However, with the presence of a positively charged
lysine, an orientation with the N terminus in the vicinity of the negatively
charged membrane surface can be inferred.
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hydrogen atoms than the hydrocarbon region and have
therefore a higher scattering length density. The unsaturated
bond in the hydrocarbon chains of POPC and POPS is
responsible for the secondary maximum at z  5.8 Å in the
scattering length density profile of the pure lipid sample
(Bu¨ldt et al., 1979). The fact that the d spacings and the
distances between the glycerol backbones do not vary be-
tween samples with and without peptide suggests that the
peptide does not induce changes in the distance between
membrane layers, in accordance with Mason et al. (1996).
The information about the location of the peptide comes
from the difference of the profiles of the two samples
containing labeled (Fig. 2 A, solid) and unlabeled (Fig. 2 A,
dashed) A. The difference of these two density maps gives
in fact the deuterium distribution in the lipid bilayers con-
taining (D-Leu-34)-A (25–35). This distribution for an-
ionic bilayers is shown in Fig. 2 B (solid line), and it
suggests two separate locations for the label. We emphasize
that this difference is in a “relative absolute scale,” as
explained in the experimental sections. To determine the
deuterium distribution in the two label positions, a model
fitting approach with two Gaussians (and their mirror im-
ages in the centrosymmetric unit cell) was considered. To
perform this fitting procedure six parameters (i.e., ampli-
tude, position, and width for each Gaussian) are necessary.
Because our measurements are limited to five diffraction
orders, we decided to use the experimental resolution as a
fixed value for the width of the Gauss functions and to
perform the fit with amplitudes and positions as free pa-
rameters. The fit results are reported in Table 2 and com-
pared with the difference density in Fig. 2 B. The striking
information is contained in the 54.0% of the deuterium
located inside the membrane core at z  5.9 Å, a position
close to the double bond of the hydrophobic chains of the
lipids. This is in qualitative agreement with the findings
described by Mason et al. (1996). In that interesting paper
based on x-ray diffraction, the authors put forward that A
(25–35) has lipophilic tendency. Our results support and
extend the previous notion of the A (25–35) being inter-
calated in the hydrocarbon core of a lipid bilayer by dem-
onstrating unambiguously that the C-terminal part is located
near the center of the membrane. The paper by Mason et al.
(1996) was hampered by the fact that no specific labeling
was applied, i.e., samples with and without peptide were
studied; this led to an overall location of the peptide relative
to the membrane. Our results refine this finding and allow
the conclusion that the C terminus has deeply penetrated
into the bilayer. Moreover, in the study by Mason et al.
(1996), the poor sensitivity of the method forced the authors
to use an extremely high peptide/lipid ratio, i.e., 1:5 peptide/
lipid mass, as compared with 1:24 in the present study. The
use of unphysiological net uncharged lipid headgroups may
also have been a limitation, because the electrostatic force
between the negatively charged neuronal membranes and
the net positively charged A plays a role in their interac-
tion, as shown by our results in the next section. Finally, the
electron density profiles are reported in a relative arbitrary
scale, which may be misleading, especially when differ-
ences are taken into account.
According to Fig. 2 B, a considerable amount of deute-
rium (46.0%) of the A is in the aqueous medium. It is
possible that a population of the peptide forms aggregates,
which are not able to penetrate into the bilayers. This is in
agreement with a previous study by Mason et al. (1999),
where aggregates of A (1–40) were located at the hydro-
philic membrane region. On the other hand, it is also plau-
sible that the peptides outside the membrane preserve the
monomeric state, but the solubility threshold into the lipid
phase has been reached. With the current data, it is not
possible to discriminate between these two possibilities.
Due to the small size of A (25–35), the population of
monomers versus aggregates cannot be detected by gel
electrophoresis as in Mason et al. (1999). As a final remark,
it can be observed that comparing the profiles of the two
samples containing A (25–35) with the pure lipid one (Fig.
2 A), a feature is clearly visible: the broadening of the region
corresponding to the polar lipid headgroups. This fact raises
the possibility of an overall disordering effect of peptide in
the lipid headgroup region of the membrane structure.
The significance of the changes induced in the scattering
length density profiles by the presence of the A (25–35)
peptide with respect to the error limits of 	(z) is illustrated
in the left side of Fig. 3. The profiles of the membranes
containing the labeled and the unlabeled peptide fragments
are revealed together with their 95% confidence envelopes.
It is clearly demonstrated that the peptide introduces
changes in the membrane profiles well outside the error
limits. The right side of Fig. 3 shows the two profiles
obtained from two independent measurements of two inde-
pendent samples in the presence of the protonated A
(25–35) peptide. These measurements demonstrate the re-
producibility of the sample preparation and measurement,
as the differences are well inside the confidence limit.
At present, investigations using an A fragment deuter-
ated on the N-terminal side are being carried out. The
TABLE 2 Results of fitting deuterium label distributions of
A (25–35) in bilayers of POPC/POPS and of POPC using
Gaussian functions defined as (z)  A/2 exp((z  z0)
2/
22) for each label position
Membrane (Å) Parameter Distribution
POPC/POPS 2.85 A (m) (1.02 0.1) 1014 54.0%
z0 (Å) 5.92  0.16
2.85 A (m) (0.86 0.15) 1014 46.0%
z0 (Å) 24  1
POPC 2.85 A (m) (1.97 0.2) 1014 86.2%
z0 (Å) 14.3  0.2
2.85 A (m) (0.31 0.09) 1014 13.8%
z0 (Å) 27.0  0.2
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localization of this label will give the orientation of the A
(25–35) inside the bilayers.
POPC multilayers
The d repeats for the samples made of uncharged lipids
were 53.9.  0.4 Å, 54.1  0.4 Å, and 54.6  0.5 Å for the
POPC, the POPC with protonated, and the POPC with
deuterated A (25–35), respectively. The spacings for the
net uncharged POPC were only approximately 3 Å smaller
with respect to the spacings of the anionic membranes.
The scattering length density profiles in presence of the
A (25–35) are shown in Fig. 4 A, together with the POPC
membrane profile. As in the case of the anionic membrane,
the d spacing and the thickness of the membrane layers are
unaffected by the presence of the peptide. The deuterium
distribution in the lipid bilayers containing (D-Leu-34)-A
(25–35) is reported in Fig. 4 B. As in the case of POPC/
POPS, two populations of the peptides are present, one
inside and one outside the lipid bilayer. The results of the
Gaussian model fit are presented in Table 2. With respect to
POPC/POPS, a larger amount of the peptide (86.2%) is
found inside the lipid membrane, but it does not intercalate
as deeply in the is found at a position corresponding to the
polar heads of the lipids, i.e., 14.3  0.2 Å from the center
of the membrane. This finding is in contrast to the study by
Mason et al. (1996) where the same net-uncharged lipid
membrane was used and the position of the peptide was
determined close to the membrane center. The remaining
13.8% of the A is localized in the aqueous medium,
however, because this value is closed to the error limit it
cannot be excluded that all the A is localized at the lipid
headgroup region. As compared with the POPC/POPS
membrane, a different behavior is observed in the lipid
headgroup region, where no broadening between the mem-
brane with and without peptide is observed.
Interaction of A with charged and
uncharged membranes
Our results are only in partial agreement with the study
by Terzi et al. (1997) on lipid monolayers at the air/water
interface. In that case, A (1–40) was found to interca-
late in the membrane in presence of anionic lipids, but
only at packing density lower than that of a lipid bilayer.
The study suggested that under physiological conditions,
the peptide only bound electrostatic to the negatively
FIGURE 3 (Left) To demonstrate the quality of the data, the scattering
length density profile of the POPC/POPS sample containing a protonated A
(25–35) is plotted (solid lines, curve a) together with the POPC/POPS sample
containing deuterated A (25–35) (curve b) on the left side and with a second
POPC/POPS sample containing protonated A (25–35) on the right side. On
the left side the confidence limits are drawn (dashed lines). For simplicity only
one-half of the unit cell is shown. The deuterons of the labeled peptide
produced larger difference in the profiles than the confidence limits around z
28.5 Å and z  5.9 Å. The right side of the figure demonstrates the
reproducibility of both sample preparation and measurements.
FIGURE 4 (A) Scattering length density times lipid area (	*(z)  S 
	(z)) along the direction normal to the membrane plane of the samples
containing deuterated (solid) and protonated (dashed) A (25–35) in the
case of a POPC membrane. The profile of a pure POPC membrane is
shown as dotted line. (B) Difference scattering length density profile, in the
case of net uncharged POPC bilayers, between the sample with protonated
and deuterated A (25–35) (solid line) and its fit with two Gaussian
distributions (dotted line), truncated to the fifth Fourier term. Two distinct
locations of the deuterated label are observed, one of them is situated in a
position corresponding to the lipid headgroups, the second in the water
layer. Due to the restricted measuring time, the measurements were done
only up to the fifth diffraction order, although in these samples higher
orders were detectable. This led to Fourier truncation errors and noise in
the Fourier density profiles.
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charged membrane. On the contrary, we observe a pref-
erential intercalation of A (25–35) with the hydrophilic
lipid headgroups in absence of negatively charged lipids.
As a matter of fact, it is not obvious that the peptide
should interact the same way with the monolayer as with
the bilayer system; differences can be expected espe-
cially when the insertion is deep inside the bilayer. More-
over, the systems investigated in the two studies differ
both for the negatively charged lipid and for the length of
the peptide used.
On the other hand, the similarities of our findings with
the behavior of a peptide belonging to the tachykinin
family, i.e., substance P, are remarkable. A (25–35) and
substance P are both 11-amino acid peptides with iden-
tical C-terminal region and with a positive charge in their
sequence. Due to this resemblance, the A (25–35) is
often referred to as the tachykinin-like region of the
Alzheimer’s -amyloid proteins, although it is not clear
if it really shares any biological activities with tachyki-
nins (El-Agnaf et al., 1998). In a previous study using
neutron diffraction (Bradshaw et al., 1998), substance P
was shown to intercalate in the membrane and moreover
the intercalation was promoted by negatively charged
lipids and hindered by zwitterionic ones. Furthermore,
the penetration depth in the lipid core is nearly identical
for the two peptides substance P and A (25–35). This
would indicate that the position of the C terminus in the
membrane core is controlled by the membrane structure.
As demonstrated by our present study and recent exper-
iments by others, lipid membranes are specific targets of A
peptides and the interaction A/membrane might play a
critical role in its neurotoxic mechanism. This is supported
by the observation that A forms cationic channels. The
exact localization of the A (25–35) C terminus in the
hydrophobic core of phospholipid bilayers, as determined in
the present study, can thus be exploited for the development
of specific therapeutic drugs.
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